Revenue rose 8% year-over-year to RMB2,705 million, but net loss widened to RMB1,416 million amid a challenging real estate market. Liquidity risks and overdue borrowings led to a disclaimer of opinion from the auditor, while the company accelerates its shift toward the health industry.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.